TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Global Type 1 Diabetes Market Insights, Forecast to 2028

Global Type 1 Diabetes Market Insights, Forecast to 2028

  • Category:Life Sciences
  • Published on : 21 July 2022
  • Pages :108
  • Formats:
  • Report Code:SMR-7222373
OfferClick for best price

Best Price: $3920

Type 1 Diabetes Market Size, Share 2022


Market Analysis and Insights: Global Type 1 Diabetes Market

The global Type 1 Diabetes market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Type 1 Diabetes market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Type 1 Diabetes market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Type 1 Diabetes market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Type 1 Diabetes market.

Global Type 1 Diabetes Scope and Market Size

Type 1 Diabetes market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Type 1 Diabetes market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Rapid Acting Insulin Analogs

Long Acting Insulin Analogs

Premix Insulin Analogs

Segment by Application

Hospitals

Diagnostic clinics

By Company

Abbott

Bayer

Eli Lilly

BD

Johnson & Johnson

Merck

Pfizer

AstraZeneca

Roche

Smiths Medical

Medtronic

By Region

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

The information for each competitor/Company Profile includes:

  • Company Overview
  • Business Strategy
  • Key Product Offerings
  • Financial Performance
  • Key Performance Indicators
  • Risk Analysis
  • Recent Development
  • Regional Presence
  • SWOT Analysis 

The content of the study subjects includes a total of 15 chapters:

Chapter 1, describes Type 1 Diabetes product scope, market overview, market opportunities, market driving force, and market risks.

Chapter 2, profiles the top manufacturers of Type 1 Diabetes, with price, sales, revenue, and global market share of Type 1 Diabetes from 2019 to 2022.

Chapter 3, the Type 1 Diabetes competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Type 1 Diabetes breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.

Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Type 1 Diabetes market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of Type 1 Diabetes.

Chapter 13, 14, and 15, to describe Type 1 Diabetes sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Key Indicators Analysed:

  • Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
  • Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
  • Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
  • Opportunities and Drivers: Identifying the Growing Demands and New Technology
  • Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Reasons to Purchase this Report:

  • Estimates 2022-2027 2021-2025 Type 1 Diabetes Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
  • Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
  • Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
  • Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • 1-year analyst support, along with the data support in excel format.

Research Methodology:

The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

Report Attributes Report Details
Report Title Global Type 1 Diabetes Market Insights, Forecast to 2028
Historical Year 2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year 2021
Forecast Year 2029
Number of Pages 108 Pages
Customization Available Yes, the report can be customized as per your need.

TABLE OF CONTENTS

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Type 1 Diabetes Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Rapid Acting Insulin Analogs
1.2.3 Long Acting Insulin Analogs
1.2.4 Premix Insulin Analogs
1.3 Market by Application
1.3.1 Global Type 1 Diabetes Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Diagnostic clinics
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Type 1 Diabetes Market Perspective (2017-2028)
2.2 Type 1 Diabetes Growth Trends by Region
2.2.1 Type 1 Diabetes Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Type 1 Diabetes Historic Market Size by Region (2017-2022)
2.2.3 Type 1 Diabetes Forecasted Market Size by Region (2023-2028)
2.3 Type 1 Diabetes Market Dynamics
2.3.1 Type 1 Diabetes Industry Trends
2.3.2 Type 1 Diabetes Market Drivers
2.3.3 Type 1 Diabetes Market Challenges
2.3.4 Type 1 Diabetes Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Type 1 Diabetes Players by Revenue
3.1.1 Global Top Type 1 Diabetes Players by Revenue (2017-2022)
3.1.2 Global Type 1 Diabetes Revenue Market Share by Players (2017-2022)
3.2 Global Type 1 Diabetes Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Type 1 Diabetes Revenue
3.4 Global Type 1 Diabetes Market Concentration Ratio
3.4.1 Global Type 1 Diabetes Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Type 1 Diabetes Revenue in 2021
3.5 Type 1 Diabetes Key Players Head office and Area Served
3.6 Key Players Type 1 Diabetes Product Solution and Service
3.7 Date of Enter into Type 1 Diabetes Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Type 1 Diabetes Breakdown Data by Type
4.1 Global Type 1 Diabetes Historic Market Size by Type (2017-2022)
4.2 Global Type 1 Diabetes Forecasted Market Size by Type (2023-2028)
5 Type 1 Diabetes Breakdown Data by Application
5.1 Global Type 1 Diabetes Historic Market Size by Application (2017-2022)
5.2 Global Type 1 Diabetes Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Type 1 Diabetes Market Size (2017-2028)
6.2 North America Type 1 Diabetes Market Size by Type
6.2.1 North America Type 1 Diabetes Market Size by Type (2017-2022)
6.2.2 North America Type 1 Diabetes Market Size by Type (2023-2028)
6.2.3 North America Type 1 Diabetes Market Share by Type (2017-2028)
6.3 North America Type 1 Diabetes Market Size by Application
6.3.1 North America Type 1 Diabetes Market Size by Application (2017-2022)
6.3.2 North America Type 1 Diabetes Market Size by Application (2023-2028)
6.3.3 North America Type 1 Diabetes Market Share by Application (2017-2028)
6.4 North America Type 1 Diabetes Market Size by Country
6.4.1 North America Type 1 Diabetes Market Size by Country (2017-2022)
6.4.2 North America Type 1 Diabetes Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Type 1 Diabetes Market Size (2017-2028)
7.2 Europe Type 1 Diabetes Market Size by Type
7.2.1 Europe Type 1 Diabetes Market Size by Type (2017-2022)
7.2.2 Europe Type 1 Diabetes Market Size by Type (2023-2028)
7.2.3 Europe Type 1 Diabetes Market Share by Type (2017-2028)
7.3 Europe Type 1 Diabetes Market Size by Application
7.3.1 Europe Type 1 Diabetes Market Size by Application (2017-2022)
7.3.2 Europe Type 1 Diabetes Market Size by Application (2023-2028)
7.3.3 Europe Type 1 Diabetes Market Share by Application (2017-2028)
7.4 Europe Type 1 Diabetes Market Size by Country
7.4.1 Europe Type 1 Diabetes Market Size by Country (2017-2022)
7.4.2 Europe Type 1 Diabetes Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Type 1 Diabetes Market Size (2017-2028)
8.2 Asia-Pacific Type 1 Diabetes Market Size by Type
8.2.1 Asia-Pacific Type 1 Diabetes Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Type 1 Diabetes Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Type 1 Diabetes Market Share by Type (2017-2028)
8.3 Asia-Pacific Type 1 Diabetes Market Size by Application
8.3.1 Asia-Pacific Type 1 Diabetes Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Type 1 Diabetes Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Type 1 Diabetes Market Share by Application (2017-2028)
8.4 Asia-Pacific Type 1 Diabetes Market Size by Region
8.4.1 Asia-Pacific Type 1 Diabetes Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Type 1 Diabetes Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Type 1 Diabetes Market Size (2017-2028)
9.2 Latin America Type 1 Diabetes Market Size by Type
9.2.1 Latin America Type 1 Diabetes Market Size by Type (2017-2022)
9.2.2 Latin America Type 1 Diabetes Market Size by Type (2023-2028)
9.2.3 Latin America Type 1 Diabetes Market Share by Type (2017-2028)
9.3 Latin America Type 1 Diabetes Market Size by Application
9.3.1 Latin America Type 1 Diabetes Market Size by Application (2017-2022)
9.3.2 Latin America Type 1 Diabetes Market Size by Application (2023-2028)
9.3.3 Latin America Type 1 Diabetes Market Share by Application (2017-2028)
9.4 Latin America Type 1 Diabetes Market Size by Country
9.4.1 Latin America Type 1 Diabetes Market Size by Country (2017-2022)
9.4.2 Latin America Type 1 Diabetes Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Type 1 Diabetes Market Size (2017-2028)
10.2 Middle East & Africa Type 1 Diabetes Market Size by Type
10.2.1 Middle East & Africa Type 1 Diabetes Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Type 1 Diabetes Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Type 1 Diabetes Market Share by Type (2017-2028)
10.3 Middle East & Africa Type 1 Diabetes Market Size by Application
10.3.1 Middle East & Africa Type 1 Diabetes Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Type 1 Diabetes Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Type 1 Diabetes Market Share by Application (2017-2028)
10.4 Middle East & Africa Type 1 Diabetes Market Size by Country
10.4.1 Middle East & Africa Type 1 Diabetes Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Type 1 Diabetes Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Type 1 Diabetes Introduction
11.1.4 Abbott Revenue in Type 1 Diabetes Business (2017-2022)
11.1.5 Abbott Recent Developments
11.2 Bayer
11.2.1 Bayer Company Details
11.2.2 Bayer Business Overview
11.2.3 Bayer Type 1 Diabetes Introduction
11.2.4 Bayer Revenue in Type 1 Diabetes Business (2017-2022)
11.2.5 Bayer Recent Developments
11.3 Eli Lilly
11.3.1 Eli Lilly Company Details
11.3.2 Eli Lilly Business Overview
11.3.3 Eli Lilly Type 1 Diabetes Introduction
11.3.4 Eli Lilly Revenue in Type 1 Diabetes Business (2017-2022)
11.3.5 Eli Lilly Recent Developments
11.4 BD
11.4.1 BD Company Details
11.4.2 BD Business Overview
11.4.3 BD Type 1 Diabetes Introduction
11.4.4 BD Revenue in Type 1 Diabetes Business (2017-2022)
11.4.5 BD Recent Developments
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Details
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Type 1 Diabetes Introduction
11.5.4 Johnson & Johnson Revenue in Type 1 Diabetes Business (2017-2022)
11.5.5 Johnson & Johnson Recent Developments
11.6 Merck
11.6.1 Merck Company Details
11.6.2 Merck Business Overview
11.6.3 Merck Type 1 Diabetes Introduction
11.6.4 Merck Revenue in Type 1 Diabetes Business (2017-2022)
11.6.5 Merck Recent Developments
11.7 Pfizer
11.7.1 Pfizer Company Details
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Type 1 Diabetes Introduction
11.7.4 Pfizer Revenue in Type 1 Diabetes Business (2017-2022)
11.7.5 Pfizer Recent Developments
11.8 AstraZeneca
11.8.1 AstraZeneca Company Details
11.8.2 AstraZeneca Business Overview
11.8.3 AstraZeneca Type 1 Diabetes Introduction
11.8.4 AstraZeneca Revenue in Type 1 Diabetes Business (2017-2022)
11.8.5 AstraZeneca Recent Developments
11.9 Roche
11.9.1 Roche Company Details
11.9.2 Roche Business Overview
11.9.3 Roche Type 1 Diabetes Introduction
11.9.4 Roche Revenue in Type 1 Diabetes Business (2017-2022)
11.9.5 Roche Recent Developments
11.10 Smiths Medical
11.10.1 Smiths Medical Company Details
11.10.2 Smiths Medical Business Overview
11.10.3 Smiths Medical Type 1 Diabetes Introduction
11.10.4 Smiths Medical Revenue in Type 1 Diabetes Business (2017-2022)
11.10.5 Smiths Medical Recent Developments
11.11 Medtronic
11.11.1 Medtronic Company Details
11.11.2 Medtronic Business Overview
11.11.3 Medtronic Type 1 Diabetes Introduction
11.11.4 Medtronic Revenue in Type 1 Diabetes Business (2017-2022)
11.11.5 Medtronic Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

LIST OF TABLES & FIGURES

List of Tables
Table 1. Global Type 1 Diabetes Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Rapid Acting Insulin Analogs
Table 3. Key Players of Long Acting Insulin Analogs
Table 4. Key Players of Premix Insulin Analogs
Table 5. Global Type 1 Diabetes Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 6. Global Type 1 Diabetes Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Type 1 Diabetes Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global Type 1 Diabetes Market Share by Region (2017-2022)
Table 9. Global Type 1 Diabetes Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global Type 1 Diabetes Market Share by Region (2023-2028)
Table 11. Type 1 Diabetes Market Trends
Table 12. Type 1 Diabetes Market Drivers
Table 13. Type 1 Diabetes Market Challenges
Table 14. Type 1 Diabetes Market Restraints
Table 15. Global Type 1 Diabetes Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global Type 1 Diabetes Revenue Share by Players (2017-2022)
Table 17. Global Top Type 1 Diabetes by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Type 1 Diabetes as of 2021)
Table 18. Ranking of Global Top Type 1 Diabetes Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by Type 1 Diabetes Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Type 1 Diabetes Product Solution and Service
Table 22. Date of Enter into Type 1 Diabetes Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Type 1 Diabetes Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global Type 1 Diabetes Revenue Market Share by Type (2017-2022)
Table 26. Global Type 1 Diabetes Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global Type 1 Diabetes Revenue Market Share by Type (2023-2028)
Table 28. Global Type 1 Diabetes Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global Type 1 Diabetes Revenue Share by Application (2017-2022)
Table 30. Global Type 1 Diabetes Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global Type 1 Diabetes Revenue Share by Application (2023-2028)
Table 32. North America Type 1 Diabetes Market Size by Type (2017-2022) & (US$ Million)
Table 33. North America Type 1 Diabetes Market Size by Type (2023-2028) & (US$ Million)
Table 34. North America Type 1 Diabetes Market Size by Application (2017-2022) & (US$ Million)
Table 35. North America Type 1 Diabetes Market Size by Application (2023-2028) & (US$ Million)
Table 36. North America Type 1 Diabetes Market Size by Country (2017-2022) & (US$ Million)
Table 37. North America Type 1 Diabetes Market Size by Country (2023-2028) & (US$ Million)
Table 38. Europe Type 1 Diabetes Market Size by Type (2017-2022) & (US$ Million)
Table 39. Europe Type 1 Diabetes Market Size by Type (2023-2028) & (US$ Million)
Table 40. Europe Type 1 Diabetes Market Size by Application (2017-2022) & (US$ Million)
Table 41. Europe Type 1 Diabetes Market Size by Application (2023-2028) & (US$ Million)
Table 42. Europe Type 1 Diabetes Market Size by Country (2017-2022) & (US$ Million)
Table 43. Europe Type 1 Diabetes Market Size by Country (2023-2028) & (US$ Million)
Table 44. Asia Pacific Type 1 Diabetes Market Size by Type (2017-2022) & (US$ Million)
Table 45. Asia Pacific Type 1 Diabetes Market Size by Type (2023-2028) & (US$ Million)
Table 46. Asia Pacific Type 1 Diabetes Market Size by Application (2017-2022) & (US$ Million)
Table 47. Asia Pacific Type 1 Diabetes Market Size by Application (2023-2028) & (US$ Million)
Table 48. Asia Pacific Type 1 Diabetes Market Size by Region (2017-2022) & (US$ Million)
Table 49. Asia Pacific Type 1 Diabetes Market Size by Region (2023-2028) & (US$ Million)
Table 50. Latin America Type 1 Diabetes Market Size by Type (2017-2022) & (US$ Million)
Table 51. Latin America Type 1 Diabetes Market Size by Type (2023-2028) & (US$ Million)
Table 52. Latin America Type 1 Diabetes Market Size by Application (2017-2022) & (US$ Million)
Table 53. Latin America Type 1 Diabetes Market Size by Application (2023-2028) & (US$ Million)
Table 54. Latin America Type 1 Diabetes Market Size by Country (2017-2022) & (US$ Million)
Table 55. Latin America Type 1 Diabetes Market Size by Country (2023-2028) & (US$ Million)
Table 56. Middle East and Africa Type 1 Diabetes Market Size by Type (2017-2022) & (US$ Million)
Table 57. Middle East and Africa Type 1 Diabetes Market Size by Type (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Type 1 Diabetes Market Size by Application (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Type 1 Diabetes Market Size by Application (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Type 1 Diabetes Market Size by Country (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Type 1 Diabetes Market Size by Country (2023-2028) & (US$ Million)
Table 62. Abbott Company Details
Table 63. Abbott Business Overview
Table 64. Abbott Type 1 Diabetes Product
Table 65. Abbott Revenue in Type 1 Diabetes Business (2017-2022) & (US$ Million)
Table 66. Abbott Recent Developments
Table 67. Bayer Company Details
Table 68. Bayer Business Overview
Table 69. Bayer Type 1 Diabetes Product
Table 70. Bayer Revenue in Type 1 Diabetes Business (2017-2022) & (US$ Million)
Table 71. Bayer Recent Developments
Table 72. Eli Lilly Company Details
Table 73. Eli Lilly Business Overview
Table 74. Eli Lilly Type 1 Diabetes Product
Table 75. Eli Lilly Revenue in Type 1 Diabetes Business (2017-2022) & (US$ Million)
Table 76. Eli Lilly Recent Developments
Table 77. BD Company Details
Table 78. BD Business Overview
Table 79. BD Type 1 Diabetes Product
Table 80. BD Revenue in Type 1 Diabetes Business (2017-2022) & (US$ Million)
Table 81. BD Recent Developments
Table 82. Johnson & Johnson Company Details
Table 83. Johnson & Johnson Business Overview
Table 84. Johnson & Johnson Type 1 Diabetes Product
Table 85. Johnson & Johnson Revenue in Type 1 Diabetes Business (2017-2022) & (US$ Million)
Table 86. Johnson & Johnson Recent Developments
Table 87. Merck Company Details
Table 88. Merck Business Overview
Table 89. Merck Type 1 Diabetes Product
Table 90. Merck Revenue in Type 1 Diabetes Business (2017-2022) & (US$ Million)
Table 91. Merck Recent Developments
Table 92. Pfizer Company Details
Table 93. Pfizer Business Overview
Table 94. Pfizer Type 1 Diabetes Product
Table 95. Pfizer Revenue in Type 1 Diabetes Business (2017-2022) & (US$ Million)
Table 96. Pfizer Recent Developments
Table 97. AstraZeneca Company Details
Table 98. AstraZeneca Business Overview
Table 99. AstraZeneca Type 1 Diabetes Product
Table 100. AstraZeneca Revenue in Type 1 Diabetes Business (2017-2022) & (US$ Million)
Table 101. AstraZeneca Recent Developments
Table 102. Roche Company Details
Table 103. Roche Business Overview
Table 104. Roche Type 1 Diabetes Product
Table 105. Roche Revenue in Type 1 Diabetes Business (2017-2022) & (US$ Million)
Table 106. Roche Recent Developments
Table 107. Smiths Medical Company Details
Table 108. Smiths Medical Business Overview
Table 109. Smiths Medical Type 1 Diabetes Product
Table 110. Smiths Medical Revenue in Type 1 Diabetes Business (2017-2022) & (US$ Million)
Table 111. Smiths Medical Recent Developments
Table 112. Medtronic Company Details
Table 113. Medtronic Business Overview
Table 114. Medtronic Type 1 Diabetes Product
Table 115. Medtronic Revenue in Type 1 Diabetes Business (2017-2022) & (US$ Million)
Table 116. Medtronic Recent Developments
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Type 1 Diabetes Market Share by Type: 2021 VS 2028
Figure 2. Rapid Acting Insulin Analogs Features
Figure 3. Long Acting Insulin Analogs Features
Figure 4. Premix Insulin Analogs Features
Figure 5. Global Type 1 Diabetes Market Share by Application: 2021 VS 2028
Figure 6. Hospitals Case Studies
Figure 7. Diagnostic clinics Case Studies
Figure 8. Type 1 Diabetes Report Years Considered
Figure 9. Global Type 1 Diabetes Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 10. Global Type 1 Diabetes Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Type 1 Diabetes Market Share by Region: 2021 VS 2028
Figure 12. Global Type 1 Diabetes Market Share by Players in 2021
Figure 13. Global Top Type 1 Diabetes Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Type 1 Diabetes as of 2021)
Figure 14. The Top 10 and 5 Players Market Share by Type 1 Diabetes Revenue in 2021
Figure 15. North America Type 1 Diabetes Market Size YoY (2017-2028) & (US$ Million)
Figure 16. North America Type 1 Diabetes Market Size Market Share by Type (2017-2028)
Figure 17. North America Type 1 Diabetes Market Size Market Share by Application (2017-2028)
Figure 18. North America Type 1 Diabetes Market Size Share by Country (2017-2028)
Figure 19. United States Type 1 Diabetes Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Canada Type 1 Diabetes Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Type 1 Diabetes Market Size YoY (2017-2028) & (US$ Million)
Figure 22. Europe Type 1 Diabetes Market Size Market Share by Type (2017-2028)
Figure 23. Europe Type 1 Diabetes Market Size Market Share by Application (2017-2028)
Figure 24. Europe Type 1 Diabetes Market Size Share by Country (2017-2028)
Figure 25. Germany Type 1 Diabetes Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. France Type 1 Diabetes Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. U.K. Type 1 Diabetes Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Italy Type 1 Diabetes Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Russia Type 1 Diabetes Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Nordic Countries Type 1 Diabetes Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Asia-Pacific Type 1 Diabetes Market Size YoY (2017-2028) & (US$ Million)
Figure 32. Asia Pacific Type 1 Diabetes Market Size Market Share by Type (2017-2028)
Figure 33. Asia Pacific Type 1 Diabetes Market Size Market Share by Application (2017-2028)
Figure 34. Asia Pacific Type 1 Diabetes Market Size Share by Region (2017-2028)
Figure 35. China Type 1 Diabetes Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Japan Type 1 Diabetes Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. South Korea Type 1 Diabetes Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Southeast Asia Type 1 Diabetes Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. India Type 1 Diabetes Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Australia Type 1 Diabetes Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 41. Latin America Type 1 Diabetes Market Size YoY (2017-2028) & (US$ Million)
Figure 42. Latin America Type 1 Diabetes Market Size Market Share by Type (2017-2028)
Figure 43. Latin America Type 1 Diabetes Market Size Market Share by Application (2017-2028)
Figure 44. Latin America Type 1 Diabetes Market Size Share by Country (2017-2028)
Figure 45. Mexico Type 1 Diabetes Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Brazil Type 1 Diabetes Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Middle East & Africa Type 1 Diabetes Market Size YoY (2017-2028) & (US$ Million)
Figure 48. Middle East and Africa Type 1 Diabetes Market Size Market Share by Type (2017-2028)
Figure 49. Middle East and Africa Type 1 Diabetes Market Size Market Share by Application (2017-2028)
Figure 50. Middle East and Africa Type 1 Diabetes Market Size Share by Country (2017-2028)
Figure 51. Turkey Type 1 Diabetes Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 52. Saudi Arabia Type 1 Diabetes Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. UAE Type 1 Diabetes Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Abbott Revenue Growth Rate in Type 1 Diabetes Business (2017-2022)
Figure 55. Bayer Revenue Growth Rate in Type 1 Diabetes Business (2017-2022)
Figure 56. Eli Lilly Revenue Growth Rate in Type 1 Diabetes Business (2017-2022)
Figure 57. BD Revenue Growth Rate in Type 1 Diabetes Business (2017-2022)
Figure 58. Johnson & Johnson Revenue Growth Rate in Type 1 Diabetes Business (2017-2022)
Figure 59. Merck Revenue Growth Rate in Type 1 Diabetes Business (2017-2022)
Figure 60. Pfizer Revenue Growth Rate in Type 1 Diabetes Business (2017-2022)
Figure 61. AstraZeneca Revenue Growth Rate in Type 1 Diabetes Business (2017-2022)
Figure 62. Roche Revenue Growth Rate in Type 1 Diabetes Business (2017-2022)
Figure 63. Smiths Medical Revenue Growth Rate in Type 1 Diabetes Business (2017-2022)
Figure 64. Medtronic Revenue Growth Rate in Type 1 Diabetes Business (2017-2022)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed

REPORT PURCHASE OPTIONS

USD Single User Price
USD Multi User Price
USD Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount